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Abstract
Chronic wounds infections (CWI) are a rising global problem, being responsible for
considerable morbidity and decreased life quality. Resulting from microorganism colo-
nization and biofilm establishment, CWI occur in patients with underlying pathologies
that hinder wound healing. Current therapies have proven to be insufficient, with the
rise and dissemination of antibiotic-resistant microorganisms.
Herein, a new antibiotic-free chitosan-based dressing material with antimicrobial
peptides (AMPs) was developed to mitigate CWI. AMPs are small peptides with broad
spectrum of activity and low propensity for inducing resistance. Unfortunately, AMPs
are easily degraded in vivo and can self-aggregate. Hence, covalent immobilization may
be an efficient strategy to improve bioavailability.
In this context, Dhvar5 (LLLFLLKKRKKRKY) was covalently immobilized onto chi-
tosan through the highly efficient photoinitiated thiol-norbornene “click” chemistry.
Dhvar5 is a synthetic AMP derived from histatin-5 with promising antimicrobial activity.
Chitosan is a biopolymer amenable to functionalization with antimicrobial, hemostatic
and prohealing properties.
To allow the chemistry, chitosan was functionalized with a norbornene group (Nor-
Chit). Dhvar5 modified with a spacer and a cysteine either at N- or C-terminal, was
used to chemoselectively immobilize the AMP. The immobilization was confirmed by
Fourier-transform infrared spectroscopy and X-ray photoelectron spectroscopy. Prote-
olytic stability of the immobilized AMP was investigated with trypsin by a competitive
assay with N-α-benzoylarginine ethylester. However, the results were inconclusive due
to a pH mismatch.
NorChit-Dhvar5 coatings were produced by spin-coating, to assess its potential in
attributing antimicrobial properties to wound dressings. NorChit-Dhvar5 coatings were
characterized by ellipsometry and water contact angle, and its antimicrobial efficacy was
evaluated against Staphylococcus epidermidis using a LIVE/DEAD Bacterial Viability Kit.
Both NorChit-Dhvar5 (Nt and Ct) coatings revealed improved antimicrobial activity in
comparison to chitosan, with lower adhered live bacteria percentages (∼ 75%). NorChit-
Dhvar5 (Nt) also presented lower number of total adhered bacteria (less 35%). Therefore,
NorChit-Dhvar5 represent promising biomaterial for future antimicrobial wound dress-
ing development.
ix
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Resumo
Infeções em feridas crónicas (IFC) são um problema global em crescimento, provo-
cando considerável morbidade e diminuição de qualidade de vida dos pacientes. Estas in-
feções são resultantes da colonização da ferida crónica por microrganismos e consequente
desenvolvimento de biofilme, e ocorrem preferencialmente em pacientes com patologias
concomitantes que agravam a cicatrização de feridas. As terapias atuais de combate a
infeção provaram ser insuficientes, em particular, com o crescimento e propagação de
microrganismos resistentes a antibióticos.
Neste trabalho, foi desenvolvido um novo material para pensos para mitigar IFC sem
uso de antibióticos, baseado em quitosano conjugado a péptidos antimicrobianos (PAMs).
Os PAMs são péptidos curtos com amplo espetro de atividade e com pouca propensão
a induzir resistência. Contudo, os PAMs são facilmente degradados in vivo, podendo
autoagregar-se. Dessa forma, a imobilização covalente surge como estratégia eficiente
para melhorar a sua biodisponibilidade.
Neste contexto, Dhvar5 (LLLFLLKKRKKRKY) foi covalentemente imobilizado a qui-
tosano através da eficiente química “click” tiol-norborneno fotoiniciada. Dhvar5 é um
PAM sintético derivado da histatin-5 com atividade antimicrobiana promissora. O qui-
tosano é um biopolímero facilmente funcionalizável com propriedades antimicrobianas,
hemostáticas e curativas.
Para permitir a aplicação da química, o quitosano foi funcionalizado com um grupo
norborneno (NorChit). Dhvar5 modificado com um espaçador e uma cisteína no C- e
N-terminal, foi usado para imobilizar de forma orientada o AMP. A imobilização foi
confirmada por espetroscopia de infravermelhos por transformada de Fourier e por es-
petroscopia de fotoeletrões de raio-X. A estabilidade proteolítica do PAM imobilizado
foi investigada com tripsina através de um ensaio competitivo com éster etílico de ben-
zoila N-α-arginina. No entanto, os resultados obtidos foram inconclusivos, devido a uma
incompatibilidade de pH.
Os revestimentos de NorChit-Dhvar5 foram produzidos por “spin-coating”, para ava-
liar o potencial deste revestimento em atribuir propriedades antimicrobianas a pensos
utilizados em feridas crónicas. Os revestimentos de NorChit-Dhvar5 foram caracterizados
por elipsometria e ângulos de contacto com a água, e a sua eficácia antimicrobiana foi
xi
avaliada usando Staphylococcus epidermidis, aplicando uma combinação de marcadores
fluorescentes do kit de viabilidade bacteriana LIVE/DEAD. Ambos os revestimentos de
NorChit-Dhvar5 (Nt e Ct) revelaram uma melhor atividade antibacteriana quando com-
parados com o quitosano, com menor percentagem de bactérias vivas aderidas (∼75%).
NorChit-Dhvar5 (Nt) também apresentou menor número total de bactérias (menos 35%).
Assim sendo, NorChit-Dhvar5 representa um biomaterial promissor para futura aplicação
no desenvolvimento de pensos antimicrobianos.
Palavras-chave: feridas crónicas, infeção, péptidos antimicrobianos, quitosano, química
click, tiol-norborneno
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Introduction
1.1 Context and Motivation
Chronic wounds (CW) are a rising global medical problem, being responsible for consid-
erable morbidity and decreased life quality [1]. In the United States alone, it is estimated
that 2.4-4.5 million people are affected by these wounds, being a growing problem due
to the population aging and rise in the incidence of obesity and diabetes [2]. Also, CW
represent high economic burden for healthcare systems, being estimated that 2-3% of the
health-care budget is spent in CW related care [2].
Upon skin damage, wound healing is a complex process which happens through
the sequence of four important stages: hemostasis, inflammation, proliferation, and re-
modeling [3]. In CW, wound healing does not progress normally, being stalled in the
inflammatory stage, which can prolong their healing for weeks or even months [4]. CW
onset is deeply associated with diabetes mellitus, venous/arterial diseases and aging. Di-
abetes mellitus and venous/arterial diseases impact in regular circulation of blood and
imbalance the wound healing process [1]. Aging is associated not only with a declined
mobility, which promotes the development of pressure ulcers, but also with a decrease
in the effectiveness of the immune system, which in turn reduces the body capacity
to fight microorganisms [5]. The most serious problem associated to CW is infection,
which can escalate to sepsis, or even death [4]. An infected CW is a consequence of ex-
cessive microorganism colonization, making the host response insufficient. The wound
bed microenvironment favors biofilm formation, which brings extra challenges to the in-
fected CW treatment. Biofilm-associated bacteria are protected against both host immune
system and antimicrobial drugs, being much harder to eradicate [1]. Current therapies
include the use of surgical debridement, local application of silver or antiseptics, systemic
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antibiotherapy, and in more severe, broader wounds negative pressure (vacuum) thera-
pies [4]. However, such therapies still present serious disadvantages: pain-associated to
surgical debridement [2], cytotoxic effects associated with silver dressings or antiseptics
application, emergence of antibiotic-resistant bacteria associated to systemic antibiother-
apy [4], and the re-colonization of wound dressings during the non-vacuum periods in
negative pressure wound therapy [6]. Therefore, there is an urgent need to find alter-
native therapeutic solutions to current antibiotics and antiseptics, to effectively fight
infection, without inducing toxicity or resistant bacteria. In this sense, antimicrobial
peptides (AMPs) appear as a promising alternative to classic antibiotics. AMPs are a class
of small peptides, with amphipathic and cationic character, that have broad spectrum of
activity, being highly efficient even at low concentrations, having low cytotoxic profile,
and more importantly, they have low propensity for inducing resistance. Hence, they
have been considered the most innovative anti-infective agents of the last decades [7]. In
this context, the use of AMPs to mitigate CW associated infections is a highly promising,
yet underexplored, approach.
1.2 Structure of the dissertation
In the present dissertation, a complete literature review was prepared, exposing the most
relevant and recent information on the subject in study.
Infections in CW are introduced in Chapter 2, as well as current strategies to prevent
or manage them. In the same chapter is also possible to find information about AMPs
and their promising application in this field. The aim of the present work is presented
in Chapter 4. Chapter 5 presents some of the surface characterization techniques used
in this work. Theoretical fundaments, practical applications and operating mode of the
different techniques are briefly exposed.
Materials and Methods used in the practical work can be found in Chapter 5 and the
obtained results in Chapter 6, as well as the underlying discussion. In Chapter 7 and 8
conclusions and future work are presented, respectively.
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State-of-the-art
2.1 Chronic wounds
A wound can be defined as an injury to the skin and is usually associated to damage to the
adjacent tissues. In a normal situation (acute wounds), the process of healing is divided
into four phases: hemostasis, inflammation, proliferation, and remodeling (Figure 2.1) [3].
The proper initiation, effective progression and resolution of each phase are crucial to
achieve correct tissue regeneration and wound closure.
Figure 2.1: Normal wound healing process. This process includes four phases with
different durations: hemostasis, inflammation, proliferation and remodelling.
Hemostasis is the first stage of the complex wound healing process and begins right
after the tissue injury. To prevent excessive bleeding caused by disruption of blood vessels
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and to close the wound, the formation of a clot is essential (coagulation process) [3]. The
damaged endothelial walls of the blood vessels promote adherence of platelets that release
cytokines and growth factors to facilitate coagulation. At the same time, fibrin works
as a glue to maintain the clot hardness. This first phase is quick, lasting seconds to few
hours [8].
Inflammation phase then initiates, and it usually lasts 24-48 hours, although it can
persist two weeks in some cases [8]. This phase involves the incoming of leukocytes (lym-
phocytes, granulocytes, monocytes, and macrophages) to the affected area, responsible
for inducing further the immune system activation. Vasodilatation with the creation of
pores in blood vessels occurs to enable the leakage of proteins and migration of leukocytes
into the wound site [5]. These cells are responsible for phagocytosis of non-functional
host cells, damaged matrix, foreign debris, bacteria-filled neutrophils and living bacteria,
playing a crucial role in this phase [9].
The proliferation phase is characterized by angiogenesis (new blood vessels forma-
tion) and reepithelialization (development of a permeability barrier). It is responsible for
covering the wound surface and for an accumulation of fibroblasts, which produce colla-
gen to restore anatomic structure and function. All these events lead to the formation of
a granulation tissue. In this phase, a contraction of the wound also occurs, and the size
of the wound becomes smaller. This phase is more prolonged than the others, usually
lasting weeks [10].
Finally, the remodeling stage is crucial regarding the maturation of the collagen pro-
duced before, which has different mechanical properties than the native tissue. There is
a change in the extracellular matrix composition, in order to form a similar tissue with
efficient functions as the intact skin. Remodeling phase can last months or, in extreme
cases, years [3].
There is still a lack of consensus regarding how chronic wounds (CW) should be
defined. It has been defined as a wound that do not heal in 4 to 6 weeks or that has
not shown a 20-40% area reduction after 2-4 weeks of optimal therapy [11]. Another
definition is simply a tissue injury that fails to heal in 12 weeks and that regularly reoc-
cur [4]. CW are known to fail in the healing process because of the prolonged stage in
the inflammation phase, possibly due to repeated trauma (pressure ulcers) or by other
underlying pathologies responsible for impaired blood flow. CW are generally assigned
to one of the next three categories: diabetic foot ulcers (DFU), pressure ulcers (PU) and
leg ulcers. DFU occur in up to 15% of all diabetic individuals, due to insufficient blood
circulation at limbs, while PU are frequently a consequence of spinal cord injuries or a
reduced mobility, causing obstruction of blood flow in some tissues. When it comes to leg
ulcers, its origin is related to a venous or arterial deficiency pathologies [1, 12]. CW are
characterized by a hypoxia environment, reduced vessel sprouting and reduced number
of fibroblasts [12]. Therefore, CW is associated to significant tissue loss which may affect
other vital structures such as bone, nerve and joints. Furthermore, the excessive produc-
tion of exudates caused by the impaired wound healing can cause maceration of healthy
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skin tissue in the vicinity of the wound [4].
2.2 Infection associated to chronic wounds: symptoms and
diagnosis
Being particularly difficult to heal, CW are easy candidates for infection onset. Early
detection of infection is key to avoid severe consequences. However, the diagnosis of in-
fection in CW can be very challenging given the frequent silent symptoms or the absence
of typical signs of infection [11]. Indeed, a vast amount of the symptoms is shared with
inflammatory symptoms, such as redness, heat, swelling, pain and induration. The pres-
ence of neuropathy in diabetic patients, for example, can mask the symptoms of infection,
which makes the clinical suspicion important when it comes to diagnosis [2]. Therefore,
the definition of infected DFU by the Consensus Development Conference on Diabetic
Foot Wound Care, states that purulent secretions or more than two signs of inflammation
must be present [11].
Typically, wound examination includes an initial visual analysis of the wound: exten-
sion, depth, location, odor, general appearance, or the presence of exudates [2]. Moreover,
a good outline of the prior trauma and history of the patient, as well as a complete study
of the current health condition, can also provide important information [2]. In order
to complement the diagnose with a less subjective evaluation, swab cultures are usually
used to identify microorganisms present in the wound. However, swab cultures only give
information about superficial colonization, and pathogens located deeply in the wound
are usually the ones responsible for the underlying infection [13]. Deep tissue cultures
could be an alternative option, given the better sensitivity and specificity in isolating
organisms responsible for the infection, but implies the establishment of a deeper wound,
that could take longer to heal [9].
2.2.1 Common etiological agents in infected chronic wounds
Although all wounds are colonized with microorganisms, infection only occurs when the
immune response of the body is not enough to compete against the bacteria that are trying
to colonize the wound [11, 13]. The factors that will determine the transition to infection
include (i) bioburden (number of bacteria living on the surface), (ii) the virulence of these
bacteria, including the ability to work as groups, and (iii) the response of the immune
system [11]. If the local infection is not addressed, it may lead to cellulitis (a common
bacterial skin infection) or, in some cases, to bacteremia and sepsis, which can be fatal [4].
A recent study showed that 28% of the patients with CW died during a 2-year follow-
up [14].
The most frequently isolated etiological agents in infected wounds include Staphylo-
coccus aureus, Pseudomonas aeruginosa, Enterococcus faecalis, Streptococcus pyogenes and
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some Proteus species [1, 4]. Adding to these, Staphylococcus epidermidis is the most fre-
quent bacteria present in the skin and therefore is often considered a contaminant when
isolated from infected CW [15]. S. epidermidis can influence the proliferation of the others
pathogenic bacteria and can be a source of antibiotic resistance genes, indicating that it
should be considered as a bacterium of impact in CW [15]. Anaerobic bacteria, such as
Peptostreptococcus, are also relevant as the low tissue oxygen level present in CW enables
the growth of these bacteria [16].
Within Gram-positive bacteria, S. aureus is an opportunistic pathogen located on
human skin and mucosal surfaces and S. epidermidis is a frequent colonizer. In acute
wounds, S. aureus produces virulence factors that are inactivated by the immune system
and consequently cause bacterial destruction [17]. On the other hand, in infected CW, S.
aureus produces specific proteins that hinders neutrophils phagocytose or impairs their
migration from blood vessels into the tissue [18]. In addition, this bacterium also secrets
a group of exoproteins that converts local host tissue into essential nutrients for bacterial
growth [18]. Regarding S. epidermidis, particular bacterial exopolymers assist them in
evading antibody recognition, which impairs the immune system, and may explain the
less efficient activity of immune system against prevalent colonizing bacteria [15]. Within
Gram-negative bacteria, P. aeruginosa is the most relevant, and is usually located in the
deepest region of wound bed, being able of invading adjacent healthy tissue [17]. The
strongest virulence factor of this bacteria is deeply correlated with its ability to biofilm
formation.
2.2.2 Biofilms
It is estimated that biofilms are present on at least 70% of CW [19]. Biofilms are defined as
an aggregation of a high-density population of microorganisms, surrounded by a matrix
composed of extracellular polymeric substances (EPS), nucleic acids, proteins and lipids.
This matrix is separated by open water channels that provide the delivery of nutrients, as
well as the removal of metabolic waste products [19]. A biofilm creates a very protective
environment for bacteria. In addition, proteins (fibronectin, collagen) and damaged
tissues present in the wound, enables not only bacterial colonization, but also biofilm
formation [1, 11]. As shown in figure 2.2, biofilm formation is composed by three stages:
(i) attachment, (ii) maturation and (iii) dispersion [19].
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Figure 2.2: Biofilm formation phases: attachment, maturation and dispersion.
In the first phase, planktonic bacteria attach to the damaged tissue. While this phase
is reversible, the second phase is characterized by irreversible attachment and production
of the EPS matrix. In the last phase, propagation of the infection by cell detachment can
occur, which can lead to sepsis [16]. The persistence of biofilm hinders not only host
immune response but also the activity of antibiotics [20]. This reduced susceptibility is
mainly caused by a combination of factors such as the difficulty of immune cells/antibi-
otics penetrate in the biofilm as a result of physical protection provided by the biofilm
matrix. Moreover, the gradient of available nutrients promotes different levels of bacte-
rial metabolism, creating the so-called “persister cells”, whose low metabolism induce
less susceptibility to many antimicrobial agents [19, 20]. The “persister cells” are located
in the deeper layer of the biofilm, where oxygen density is very limited. Consequently,
they are in a dormant state, although they can become planktonic and metabolic active in
some conditions, such as during fluctuations in bacterial cell population density. As many
antibiotics target fundamental cellular processes, only growing bacteria are affected, and
therefore “persister cells” are not recognized [20]. Hence, biofilms can be 1000 times
more resistant to antibiotics than planktonic cells of the same bacterial species [20, 21].
Given the difficulty of eliminating biofilms, biofilm-associated infections represent a
substantial hurdle for therapeutic action.
2.3 Current therapies for chronic wounds
There are prerequisites to guarantee therapies effectiveness against CW, such as low
necrotic burden in the wound bed, minimal presence of inflammation, controllable bac-
terial load and presence of host cells capable of regenerating the injured tissue [13]. To
ensure these prerequisites, wound bed preparation is a crucial step. The TIME acronym
has been widely used in recent years to facilitate correct establishment of wound care.
TIME refers to Tissue assessment (presence of non-viable or necrotic tissue, for example),
Infection or Inflammation (visible signs or symptoms of these two states), Moisture im-
balance (excess of dryness or wetness), and Edge of wound (identification if the edges
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are progressing or not) [5]. After the recognition of the present conditions, the treatment
scheme is then chosen. There are a wide-ranging of available procedures to establish
the most tailored treatment including debridement, topical therapies based on growth
factors, wound dressings (with or without antimicrobial agents), antibiotic systemic ad-
ministration, negative pressure wound therapy, among others [2]. Therefore, the process
of wound management is usually a combination of therapies and not only the applica-
tion of a single procedure [9]. The most frequently used procedures to manage CW and
infected-CW are described below in more detail.
2.3.1 Debridement
Debridement plays a vital role in wound bed preparation and consists on the removal of
the necrotic or non-viable tissue in the injury area. Debridement helps to reduce fibrin
and improve wound healing rate. The main goal is the exposure of healthy tissue, which
is well-perfused and able to allow epithelial cells migration and proliferation into the
wound bed. At the same time, non-healthy tissue, responsible for slowing the wound
healing, is removed. A salient feature of this procedure is the reduction of bacteria load,
as the removal of the non-healthy tissue hinders bacterial colonization, promoting the
prevention of infection establishment [5].
Currently, there are five debridement methods that can be applied individually or in
combination, namely surgical, autolytic, enzymatic, biosurgical/biodebridement and me-
chanical debridement [9]. Surgical debridement is practiced by a surgeon that makes use
of surgical instruments to remove the non-viable tissue, as well as the bacterial biofilms
responsible for extending the inflammation stage of the chronic wound [2]. It is faster
and considered to be the most efficient method of debridement, but it can remove non-
damaged tissue and it often leads to an irregular wound bed [9]. Autolytic debridement
takes advantage on the endogenous enzymes present in the wound, responsible for fibrin
degradation process, and the local moisture, to re-hydrate and degrade the necrotic tissue.
This kind of debridement is more suited for wounds with non-extensive necrotic tissues
and when infection is not present [9]. Although the selectivity of the process, it can be
time-consuming and the capacity to remove devitalized tissue is limited, as it can also
destroy adjacent tissues [13, 22]. Enzymatic debridement is a minimally invasive method
that uses exogenous proteolytic enzymes to debride necrotic wound tissue. Its use is re-
stricted to wounds that are not considerably deep, extensive, or burn wound, neither may
have high bacterial burden [9]. Biosurgical debridement is been used in patients not suit-
able for surgical debridement and it is characterized by the application of larvae/maggots
to a wound. The maggots can consume the necrotic tissue, improving healing in CW [2,
9]. However, more studies are needed to prove its effectiveness [9]. Finally, mechanical
debridement includes the use of dressings, and it removes drainage and, consequently,
the necrotic tissue of the wound. Though the promptness of the method, it is usually
painful and non-selective, as it can also remove viable tissue [13].
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2.3.2 Growth factors
Growth factors (GF) are crucial in wound healing by playing a vital role in communication
between cells and their microenvironment. They are involved in processes such as the
formation of granulation tissue, inflammatory response and angiogenesis [23]. Changes
in the normal expression and activation of vascular endothelial growth factor, such as
abnormalities in vascular endothelial growth factor receptors (VEGFRs), are considered
culprits of wound chronicity and non-healing [24].
Others GF with reduced levels in CW are platelet-derived growth factor (PDGF) and
epidermal growth factor (EGF). PDGF is responsible for regulate cell division and their
response to chemical signs in macrophages, fibroblasts, etc. EGF stimulates the prolifera-
tion of vascular endothelial cells, keratinocytes and fibroblasts [23].
Given the correlation between GF and the wound healing process, the use of growth
factor in infection control has been practiced. Therefore, topical administration is avail-
able in the form of gels, creams and ointments. However, the effectiveness of this strategy
is limited due to the rapid elimination by exudation in the wound and difficult pene-
tration through surrounding skin layer. Moreover, the need of high doses or repeated
administration may be associated with side effects as cancer [24].
The difficulty in the success of GF therapies in clinical practice are related to its
duration of action due to their short half-life and fast proteolytic degradation in biological
environment [25].
2.3.3 Wound dressings
Many wound dressings have been developed to support the wound healing process and
to protect the wound from infection [9]. Traditional dressings, such as gauze, are made to
compress and protect the wound from the environment/contamination. Gauze, being the
most commonly used absorptive dressing, is very effective at drawing fluids and exudates
away from the wound surface. However, it can get saturated easily and it adheres to the
wound bed, which requires regular dressing changes resulting in pain on removal [26].
On the other hand, modern dressings are designed to maintain a moist environment for
the wound healing. As an example, foam dressings are highly absorptive and do not stick
to the wound, being easily removed. However, they are not adequate to patients with a
very active lifestyle since they are non-adherent [26]. Hydrogels dressings, made with
a hydrophilic polymer and more than 80% of water, are also very used for enabling the
rehydration of the wound [27]. Chitosan, a Food and Drug Administration (FDA) ap-
proved natural polymer, is a widely popular wound dressing material due to its inherent
properties such as biocompatibility, antimicrobial properties, biodegradability and bioad-
hesiveness [28]. Moreover, chitosan is associated with haemostatic effects, controlling
blood loss [29]. It has also the capacity to enhance cell proliferation and induce wound
healing [30]. Chitosan has the advantage of being easily processed into gels, nanofibers,
membranes, scaffolds, sponge-like forms, etc. [30]. For these reasons, this biopolymer
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has a vast number of reported biomedical applications, namely in the creation of wound
dressings [31, 32].
Newer technologies involve the incorporation of active antimicrobial compounds into
dressings, allowing its controlled release at the wound surface. Therefore, the use of
these dressings not only improve therapeutic outcomes but also enables a reduction in
the frequency of dressing change [4]. The antimicrobial agents can be in the form of
antiseptics (such as silver), or antibiotics [27].
2.3.4 Antiseptic (Silver)
Antiseptics are defined as non-selective antimicrobial substances that inhibit or stop the
activity/proliferation of microorganisms and they are used to stop the spread of infection.
They are usually applied with the aim of inducing irreversible inactivation of bacteria,
viruses, and fungi, preventing the occurrence of infection, reinfection and promoting
wound healing [16].
Silver-impregnated dressings have been popular antimicrobial dressings over the
years [27]. Silver, in its elementary form, does not have any critical role in the wound
healing process, neither have antimicrobial activity. However, when positively charged
(Ag+), it has antimicrobial activity against viruses, fungi, and many bacteria. Its ionized
form can be obtained in the presence of moisture (exudate in the case of wounds), being
therefore available to bind to thiol groups expressed by bacterial cells, compromising
the viability of these microorganisms [4, 16]. Silver ions can act by blocking nutrient
transport through bacterial cell walls, denaturing proteins involved in microbial respi-
ration, or by interfering with microbial DNA or RNA [33]. However, the application of
these dressings has not obtained consensus within healthcare professionals since it has
been associated with cytotoxicity due to non-degradability of the metal ions, which can
damage healthy tissues or cells that are essential to wound healing [26].
2.3.5 Antibiotics
Antibiotics are widely used to stop bacteria from growing and, thereby, to treat infections.
They are well known for its antimicrobial properties as they can inhibit (bacteriostatic
activity) or kill (bactericidal activity) microorganisms. They usually have a specific tar-
get involved in processes that occur in growing bacteria such as protein or biological
metabolic compounds synthesis [34]. The number of used topical antibiotic agents nowa-
days is substantially smaller, including fusidic acid and bacitracin [35]. Although topical
antibiotics may reduce bacterial burden in critically colonized wounds, their usage can
sensitize the skin and be associated with allergy or, more importantly, with antibiotic
resistance [33]. Moreover, the use of topical antibiotics has limited effect in the presence
of biofilm and advancing infections [36].
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Hence, when the degree of wound infection exceeds what can be controlled by lo-
cal interventions, administration of systemic antibiotic is preferred [36]. However, sys-
temic administration of antibiotics may not be effective enough due to: (i) poor in situ
biodisponibility, related to the poorly vascularized tissue present in CW which causes
subtherapeutic antibiotic concentration at the local, and (ii) development of bacterial
resistance, contributing both to efficacy loss [37]. Bacteria resistance arises from several
mechanisms that vary from species to species, such as inhibition/modification of the
susceptible drug-target or efflux of the drug from bacterial cells [34]. Moreover, acquired
resistance can result from the transfer of the genetic mutations related to the antibiotic
target [20, 37].
In this sense, antibiotherapy systemic administration is reserved to more severe cases
such as osteomyelitis, sepsis, abscess formation, lymphangitis, cellulitis and other signs
of invasive tissue infection [11].
2.3.6 Negative Pressure Wound Therapy
Negative Pressure Wound Therapy (NPWT) was introduced in the mid-1990s and is
still under research nowadays. NPWT has shown utility in wounds that are difficult
to dress and that lose a large amount of fluid [38]. Its indication includes wounds at
the fascial level or with bone/tendon exposure, and deep residual burn wounds [38, 39].
This technology consists in a coated sponge (made of “black” polyurethane or “white”
polyvinyl alcohol foam), coated with a specific sealed dressing and connected to a vacuum
device (Figure 2.3), which enables the creation of negative pressure into the wound cavity
by applying a continued vacuum [4, 39]. This procedure allows the isolation of the
wound from the environment full of bacteria, preventing wound invasion and improving
bacterial removal. Furthermore, it increases blood flow, not only in the wound center but
also in its edges, stimulates angiogenesis, promotes the formation of granulation tissue
and removes exudate (preventing excessive moisture) [4, 39].
11
CHAPTER 2. STATE-OF-THE-ART
Figure 2.3: Negative Pressure Wound Therapy scheme. This therapy consists on an open
cell foam dressing that covers the wound cavity and that is connected to a vacuum device.
Adapted from [40]
It has been proven that a pressure of 125 mmHg can be sufficient to promote wound
healing, being generally applied in intermittent periods (usually for four hours) [39].
However, during the non-vacuum periods, re-colonization by the live bacteria retained in
the sponge may occur, representing a significant problem to be solved and preventing its
use in infected wounds [6]. Silver-coated NPWT dressings have been used by releasing
silver locally from the polyurethane dressing, but the aforementioned disadvantages
associated with these antimicrobial agents still remain a problem [39].
2.4 Development of anti-infective biomaterials
Development of anti-infective biomaterials have progressively become a primary strategy
to prevent or treat human infections [41–45]. Current strategies involve the creation of a
low adhesion/bacterial repulsion surface, bactericidal surface or antimicrobial-releasing
surfaces (Figure 2.4).
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Figure 2.4: Schematic representation of different approaches for anti-infective surfaces
development.
2.4.1 Low adhesion/bacterial repulsion biomaterials
Low adhesion or bacterial repulsion surfaces may avoid or prevent bacterial attachment
and, therefore, prevent biofilm formation. This can be achieved by modifying the mor-
phology or wettability of the surfaces or by coating them with antiadhesive polymers [42,
46].
Superhydrophobic surfaces are associated with bacterial antiadhesion properties [47].
A common way to fabricate these surfaces is by changing the rough surface topography.
When a drop of water contacts a rough surface, it is repelled by the air entrapped inside
the roughness grooves which reduces the adhesion forces between the water and the
surface. Therefore, when bacteria deposit on these surfaces, they can be taken away by
the water droplet rolling off [46].
Some polymers, with bacterial antiadhesion properties, can be used as coatings.
Polyethylene glycol (PEG), a hydrophilic polymer, have been widely used in this field
due to both hydration and steric hindrance effects [48]. In aqueous environment, the
accumulation of water molecules in PEG surfaces creates a physical barrier for the ad-
sorption of bacteria (steric repulsion) [42]. However, PEG autoxidizes rapidly in the
presence of oxygen, metal ions and enzymes, which limits their long-term application in
vivo [48]. Another example are heparin coatings, which can also inhibit bacterial attach-
ment by increasing hydrophilicity of the surfaces. In fact, heparin even in solution was
proven to interfere with S. epidermidis adhesion [44].
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2.4.2 Bactericidal biomaterials
Another efficient anti-infective approach consists in depositing a bactericidal layer on the
material’s surface that can kill microorganisms on contact [44].
Examples of such surfaces include the application of metals, grafted antibiotics, or
specific topographies such as nanopatterned cicada wing surfaces [45]. Metals are known
for having bactericidal properties, such as silver, zinc and copper [41]. Silver is the most
commonly used metal for anti-infective biomedical applications for its particular high
antimicrobial activity, as mentioned above [27, 33, 44]. However, there are still some
issues regarding metals application due to the low threshold concentration for cytotoxic
effects due to the released metal ions [26, 45].
A further possibility is often by incorporating molecules with antimicrobial proper-
ties into polymers, enhancing their antimicrobial potential [44]. This could be achieved
by simple or complex covalent methods and including usage of linkers/spacers, which
provides a non-release of the antimicrobials. Antimicrobial peptides, for example, can
be used in polymer’s functionalization and still retain their ability to bind and kill bacte-
ria [21]. On the other hand, the bactericidal effect of cicada wing surfaces is exclusively
due to the surface topography rather than a surface chemical effect. The tiny cone-like
structures present on the surface lead to membrane rupture of the adhered bacteria [45].
2.4.3 Antimicrobial-releasing biomaterials
Alternatively, surfaces can be impregnated with antimicrobial agents that are gradually
released into the surrounding solution over time and that can kill microorganisms therein.
In this sense, the release can occur by different methods such as diffusion to the aqueous
phase or erosion/degradation of resorbable loaded matrices [44]. Particularly, several
wound dressings with loaded antibiotics or antiseptics have been developed [49, 50].
The major limitation regarding antimicrobial-releasing surfaces is associated with the
difficulty of controlled drug release. Many coatings release an initial large portion of
the antimicrobial substances (burst release) followed by a subsequent very low released
amount, which will cause loss of activity over time, achieving subtherapeutic concentra-
tions, related with bacterial resistance [45].
2.5 Finding new alternatives (to manage infected chronic
wounds)
2.5.1 Antimicrobial peptides
Antimicrobial peptides (AMPs) are a potential alternative to currently used antibi-
otics [51]. Characterized by having a small size (usually 10-50 residues of amino acids),
they are part of the innate immune system of many organisms, such as animals, plants,
bacteria, fungi, viruses [52]. AMPs have a vast spectrum of advantages, including high
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target specificity, high efficiency at low concentrations and a broad spectrum of activity,
including Gram-negative and Gram-positive bacteria, multidrug-resistant bacteria, fungi,
viruses and tumor cells [53]. These biocompatible AMPs can act synergistically, enhance
antibody production and reduce tissue-damaging inflammatory response to infection [7].
AMPs were also found to have high anti-biofilm activity against the most prevalent bac-
teria in infected CW, such as S. epidermidis, S. aureus and P. aeruginosa [54]. More
importantly, AMPs have low propensity to induce bacterial resistance, which makes them
beneficial for different areas of biomedicine, especially in the control and elimination of
microbial infection [53].
AMPs can be classified according to their secondary structure in four classes: (i)
α-helix, (ii) β-sheet, (iii) extended and (iv) loop. They can also assume a combined
structure (Figure 2.5) [51, 53]. The fundamental principle common to all classes is the
molecule ability to form spatially organized clusters of hydrophobic and cationic amino
acids (amphipathic). The most common structures are α-helix, usually formed when the
peptide contacts with a membrane, and β-sheet, stabilized by 2-4 disulfide bridges [51–
53].
Figure 2.5: AMP classes according to secondary structure: a) α-helix, b) β-sheet, c) ex-
tended, d) loop and e) combined structures. Adapted from [51]
With an α-helix structure, Dhvar5 is a 14-mer synthetic peptide based on the natural
histatin-5 produced by the salivary glands [55]. This synthetic peptide has a net positive
charge at the C-terminus and a hydrophobic N-terminus. Dhvar5 has a promising an-
timicrobial activity as it has been shown bactericidal (even against MRSA) and fungicidal
activity [56–59]. Compared to histatin-5, Dhvar5 has improved resistance to proteolytic
degradation and enhanced potency in vitro [58].
2.5.2 Antimicrobial peptides mechanisms of action
Although AMPs mechanism of action is still under research for most of the peptides, it
is known that they predominantly act at the membrane level due to their simultaneously
cationic and amphipathic features. While amino acid residues such as Arginine (R), Lysine
(K) and Histidine (H) contribute to the cationic property of AMPs, bulky and nonpolar
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side chains as Tryptophan (W), Leucine (L) and Proline (P) provide lipophilic anchors
that destabilize the phospholipid bilayer [51, 52].
The specific mechanisms of membrane binding are based on differences between cells
and bacteria membranes. While the outer leaflet of the eukaryotic membranes has no
net charge, in bacteria it is negatively charged [52]. For this reason, AMPs have more
affinity to prokaryotic cells, easily binding to bacterial membranes through electrostatic
interactions due to its cationic region. Moreover, the amphipathic feature of AMPs, which
is characterized by a separation between hydrophobic and hydrophilic domains, facilitate
its insertion in the microorganism membranes, promoting lipids displacement, mem-
brane structure modifications and membrane depolarization [52, 60, 61]. The parallel
binding of the peptides compromises the bacterial membrane integrity, causing cell death
or lysis. The cholesterol present in eukaryotic cells also reduces the AMP activity by sta-
bilizing the lipid bilayer [52].
There are four current models that explain the different mechanisms of action of
membrane-active AMPs (Figure 2.6).
Figure 2.6: Current proposed models for mechanisms of action of membrane-active AMPs:
a) barrel stave model, b) carpet model, c) toroidal pore model and d) aggregate model of
antibacterial peptides action in bacterial membranes. Adapted from [53].
In the barrel stave model, the peptides interact laterally to form a specific structure
that will penetrate the lipid bilayer, similar to a protein ion channel. As a consequence,
leakage of intracellular components through these pores leads to cell death. The peptides
forming the “barrel” shape are specifically aggregated so that hydrophobic regions could
be in contact with lipid core, while the hydrophilic regions are covering the lumen of the
transmembrane pore formed (Figure 2.6a) [51].
In the carpet model, peptides are firstly aligned and accumulated parallel to the lipid
bilayer. When the concentration of these peptides reaches a threshold, permeabilization
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occurs by local destabilization of the membrane. Consequently, AMP molecules penetrate
forming a micelle and leaving holes behind (Figure 2.6b) [51, 53].
In the toroidal pore model, peptides cooperatively affect the local curvature of the
membrane, forming a peptide-lipid toroid with a high curvature (Figure 2.6c). Comparing
with the barrel stave model, the main difference is that peptides are intercalated with the
lipids, so there is no interaction between peptides [7, 51].
In the aggregate model, peptides bind to phospholipids head groups and aggregate
into the membrane without any specific orientation. The aggregation of the peptides
and lipids is similar to micelles and encapsulates water molecules or small negative ions
to reduce electrostatic repulsion between positive charged side chains. As a result, the
channels formed provide ion and small molecules leakage through the membrane (Fig-
ure 2.6d) [59].
Because AMPs target an intrinsic property of the bacteria, contrary to antibiotics, it is
not expectable that AMP effectiveness will be lost, as a higher amount of energy would
be required to redesign bacterial membranes [52].
Adding to membrane activity, some AMPs exert their antimicrobial action on intracel-
lular targets by inhibiting protein or cell-wall synthesis or interacting with DNA or RNA,
for example (Figure 2.7) [7].
Figure 2.7: Current proposed mechanisms of action of antimicrobial peptides (AMPs, in
red). Abbreviations used in the figure: OM, outer membrane; IM, inner membrane; PGN,
peptidoglycan; LTA, lipoteichoic acid; LPS, lipopolysaccharide, MLT, maltose transporter.
Adapted from [62].
The exact mechanism of action of Dhvar5 is still unclear. Some cues evidence that
the binding of the AMP to the membrane of yeast cells induces outflow of intracellular
content [61, 63]. Dhvar5 translocates through the membrane by inserting it hydropho-
bic N-terminal tail between the fatty acids side chains while its cationic hydrophilic
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C-terminal interact with the negatively charged head groups [61].
2.5.3 Antimicrobial peptides application challenges
Despite their advantages, AMPs also have some limitations regarding its clinical appli-
cation. AMPs possess a short half-life, explained by self-aggregation, aggregation with
plasma proteins and proteolytic degradation [64]. This represents a challenge when
targeting CW-associated infections [64]. Infected-CW environment is rich in enzymes
with different roles. Matrix metallopeptidases (MMPs) are an important class of pro-
teases responsible for destroying cell’s membranes and consequently assist macrophages
digestion [65]. When present in excess, MMPs may degrade the extracellular matrix, pre-
venting cellular migration and attachment. The most common MMPs in chronic wound
fluid are MMP2 and MMP9 [66]. On the other hand, neutrophils and macrophages during
inflammation phase secrete Human neutrophil elastase, responsible for lysis and removal
of damaged structural proteins and bacteria [67]. Also, bacteria such as S. aureus may
release bacterial protease V8 protease, which is responsible for pathogen dissemination
by decreasing its adhesion [68].
The short half-life of AMPs would impose the application of high dosages to achieve
effective therapeutic effect. However, in high dosages, AMP inherent hydrophobicity
correlates with hemolytic activity and other cytotoxic effects [53, 62]. Hence, there has
been extensive research towards strategies to overcome these challenges.
2.5.4 Antimicrobial peptides immobilization
AMP covalent immobilization has gain momentum as an effective strategy to surpass the
aforementioned limitations [21, 63, 69–72]. In this process, a chemical reaction between
the AMP and the surface/polymer occurs to form a stable bond, resulting in an antimi-
crobial biomaterial [71]. Tethering approaches may ensure stability and biocompatibility
of peptide while maintaining the antimicrobial role [21, 73]. Parameters such as AMP
concentration, orientation (immobilized by C-terminal, N-terminal or randomly), surface
density and exposure after immobilization can impact in the antimicrobial performance
of the conjugates. The use of a spacer with specific length and flexibility, between the
peptide and the surface, provides a degree of freedom for the AMP which can also im-
pact in its antimicrobial activity [63, 70]. A number of different chemistries have been
employed to obtain AMP-related bactericidal surfaces, such as carbodiimide chemistry
(between amines and carboxylic groups), disulfide bonds establishment, immobilization
through aldehyde groups, between others [21, 72]. However, traditional chemical reac-
tions used for polymer functionalization imply the removal of low-yield side products,
which is time-consuming. As an alternative, “click” chemistry has been pursued as a way
to promote a more specific and higher yield covalent immobilization [74, 75].
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2.5.4.1 “Click” chemistry
A "click"reaction is a chemoselective reaction that enables the exclusive interaction of
two functional groups, even when other reactive agents are present, with minimal by-
products. This means that much less purification is needed and that when by-products are
generated, they are easily removed by non-chromatographic methods [74, 75]. Moreover,
its application as a toolbox for the synthesis of peptide-conjugates with polymers has
emerged [76]. Indeed, many researchers have used “click” chemistry to immobilize AMPs
onto polymers [73, 77–88]. Table 2.1 presents the most used “click” reactions including a
brief description and associated advantages and limitations [74–76, 89–98]. Among the
different “clicks”, thiol-ene has been widely used due to its impressive versatility and
clear potential in biofunctionalization [74, 99].
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2.5.4.1.1 Thiol-ene “click” chemistry
Characterized by the reaction between thiols and “enes” (carbon-carbon double bounds),
this chemistry is a metal catalyst free and environmentally friendly “click” chemistry,
being therefore suited for biomedical applications. Such reactions are considered bio-
orthogonal, i.e, they proceed without side reactions with functional groups present in
the biological systems. Hence, thiol-ene reactions do not interfere with native biochem-
ical processes and do not result in toxic by-products as well [93]. Thiol-ene reactions
can happen between a vast range of available thiols and enes, having the advantage of
being extremely rapid, with frequent completion in few seconds [74, 99]. The chemical
environment of the double bond plays an important role in the kinetics of the reaction.
Electron-rich alkenes have in general higher reactivity compared with electron-deficient
alkenes, which promotes faster kinetics [74]. Among the vast range of available “enes”
for these reactions, reactivity follows the following order: norbornene > vinylether >
propenyl > vinylester > N-vinylamide > allylether ≈ allyltriazine ≈ allylisocyanurate >
acrylate > N-substituted maleimide > acrylonitrile ≈ methacrylate > styrene > conju-
gated diene [99]. With the exception of the first and last three species, the decline in
reactivity is due to the decreasing electron density of the double bond [99]. The high
reactivity of norbornene can be explained by the bond angle distortion, and the addi-
tion of the thiyl radical leads to a decreased ring strain [99]. In addition, there is no
homopolimerization between norbornene groups, enabling all the available norbornene
groups react with thiols [100].
Thiol-ene reactions can be promoted by two distinct ways: catalyzed thiol Michael
addition or free-radical thiol-ene addition.
Thiol Michael addition usually occurs under a nucleophilic catalyst (Figure 2.8). As a
donor of electrons, the nucleophile attacks a C double bond conjugated with an electron
withdrawing group (EWG), generating a carbanion. This carbanion attracts protons from
thiols and then produce a thiolate anion, which will further react with another C double
bond to produce the thiol-ene final product [95].
Figure 2.8: Nucleophilic catalysis of thiol-Michael addition “click” reaction.
On the other hand, thiol-ene free-radical addition is photoinitiated (Figure 2.9), which
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promotes its spatial and temporal control because initiation and termination of cross-
linking reaction, can be precisely modulated by light irradiation [100]. The kinetic of
the reaction depends of the light source wavelength. Either ultraviolet (UV) light or
visible light can ensure a good reaction kinetics without potential photodamage, however,
the efficiency of the reaction is much higher with UV light irradiation [76, 100]. The
thiol-ene free-radical reaction involves a mediated radical and is a combination of chain-
growth and step-growth processes [74]. Upon absorption of the irradiated light, the
photoinitiator leads to the formation of a thiyl radical, which is followed by a two-step
process including the direct addition of this radical across the C double bond and the
following addition of a second thiol molecule (Figure 2.9). The result is the thiol-ene
product and another thiyl radical [99]. The alternated thiol-ene coupling and production
of thiyl radical occurs in stoichiometric ratio until the depletion of the limited moiety
(thiol or norbornene) [100].
Figure 2.9: Hydrothiolation of a C=C by photoinitiated thiol-ene “click” chemistry.
Photoinitiated thiol-ene is more versatile compared to thiol Michael addition since it
does not require an activated C = C, i.e, electron deficient [99].
In AMP covalent immobilization by thiol-ene chemistry, the thiol group is usually
introduced in the AMP terminal [77, 82, 84–86]. In this sense, the use of a cysteine
residue, a natural amino acid containing a thiol in the side group, is commonly used in
peptide-conjugate synthesis due to the facile coupling in the peptide production [76].
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Aim of the work
The aim of this work is the development of a new antibiotic-free wound dressing, to be
included in Negative Pressure Wound Therapy (NPWT), to wider the use of this ther-
apy to CW under infection suspicion. In this sense, the synthetic AMP Dhvar5 will be
immobilized onto chitosan through the photoinitiated thiol-ene “click” chemistry. As
mentioned in section 2.5.1, AMPs have a broad spectrum of activity, are highly efficient
even at low concentrations, have a low cytotoxic profile and, more importantly, have a
low propensity for inducing resistance. Chitosan was chosen for being an easily func-
tionalized biopolymer that has been widely used in wound management owing to its
antimicrobial, hemostatic and prohealing properties. The photoinitiated thiol-ene “click”
chemistry allows a rapid, highly efficient and simple to execute reaction between the
AMP and the polymer.
For this purpose: (i) chitosan will be conjugated with Dhvar5; (ii) the stability of
Chitosan-Dhvar5 will be tested in the presence of proteases; (ii) Chitosan-Dhvar5 coat-
ings will be produced and characterized; and (iv) the antimicrobial efficacy of Chitosan-
Dhvar5 coatings will be tested.
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Characterization techniques
4.1 Fourier-transform infrared spectroscopy (FTIR)
Fourier-transform infrared spectroscopy (FTIR) is a useful technique applied to identify
different functional groups present in a sample. When exposed to different frequencies
of infrared radiation (IR), the functional groups bonds selectively absorb specific wave-
lengths of the radiation. In this sense, each functional group produces bond adsorptions
at different locations and intensities on the IR spectrum. By comparing an “unknown”
obtained spectrum with previously recorded reference spectra, it is possible to recognize
the functional groups present in the sample [101]. As shown in Figure 4.1, the emitted IR
radiation is collimated and focused in an interferometer. The most commonly used is the
Michelson interferometer, a device consisted of a beam splitter and two perpendicular
plane mirrors, one fixed (M1) and one moving (M2). The Michelson interferometer works
by splitting a beam into two equal amplitude beams: one that is transmitted to the M2
and other that is reflected to the M1, generating an optical path difference between the
beams. After being reflected at the mirrors, the beams return to the beam splitter to
overlap and interfere. This intensity of the resulting beam will depend on the path dif-
ference between the beams. The beam passes through the sample, focuses on a detector,
and the different intensities are plotted as a function of time (interferogram). Then, with
mathematical manipulation by using Fourier transform, the interferogram is converted
into the final desired IR spectrum, plotted by intensity versus frequency [102].
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Figure 4.1: Representative scheme of the main components that composes a FTIR system.
For biological materials, the most important spectral regions are ranging between 600
and 1450 cm−1, which are typically the fingerprint region, and between 1500 and 1700
cm−1, corresponding to the amide I and amide II region. The amide bands are especially
important for peptides and proteins due to the amide covalent bond between the amino
acids (peptide bond). The higher-wavenumber region, corresponding to frequencies be-
tween 2550 and 3500 cm−1, is related to X-H stretching vibrations such as S-H, C-H, N-H
and O-H, whereas the lower-wavenumber regions correspond to C-X vibrational frequen-
cies [103]. A limitation of this technique is the presence of water vapor in the sample area,
which can reduce the transmission of IR light and mask some important spectral details.
Therefore, water vapor interference (spectral bands at 1350-1950 cm−1 and 3600-3900
cm−1) can be minimized by pre-dry the samples and by purging the instrument with dry
air or nitrogen and/or desiccants. By doing this, atmospheric CO2 can also be removed,
reducing its contribution to the spectra [103].
4.2 X-ray photoelectron spectroscopy (XPS)
X-ray photoelectron spectroscopy (XPS) is a technique based on photoelectric effect, ap-
plied to quantify elemental composition and provide information of the elements chem-
ical state [104, 105]. This technique is highly useful in detecting surface chemical mod-
ifications, as it can confirm the introduction of new elements to the surface (with the
exceptions of H and He), as well as clarifying changes on the chemical bonds [105, 106].
The scheme of the XPS technique is represented in Figure 4.2. XPS consists in the irradia-
tion of the surface with an X-ray beam that will excite the electrons present (up to 10 nm
of depth), causing their emission [104]. The kinetic energy of the emitted electrons (Ek)
depends on the binding energy of the electron (Be), which is specific of each chemical ele-
ment, and the energy of the X-ray beam (hν). Thereby, the binding energy is determined
following the photoelectric relationship displayed in Equation 4.1:
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Be = hν −Ek (4.1)
After emission, the photoelectrons go through an electron analyzer, which measures
the kinetic energy and number of electrons that escaped, to be further detected in a
detector. Throughout the XPS analysis, the sample is kept under ultra-high vacuum to
ensure the absence of other specimens in the compartment [106, 107].
Figure 4.2: Scheme of X-ray spectroscopy technique, composed by the X-ray beam, elec-
tron analyzer and electron detector. Adapted from [108].
4.3 Ellipsometry
Ellipsometry is an optical measurement technique that measures the change in polariza-
tion, as light reflects (or transmits) from a material surface. It is very useful to determine
the thickness of thin film coatings (<100 nm) deposited onto a reflective substrate since
the state of reflective polarized lights depends on the thickness and refractive index of
the coating [109]. It is also very useful to detect surface modifications such as immobiliza-
tion of an AMP, where a thickness change is anticipated. This technique is schematically
demonstrated in Figure 4.3.
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Figure 4.3: Schematic representation of the change in polarized state of the light upon
reflection with change in the amplitude ratio ψ and phase difference ∆. Eip/Erp and
Eis/Ers represent the parallel and perpendicular components of the electric field of the
incident/reflected light, respectively, and θ represents the angle of incidence. Adapted
from [110].
Light can be described as an electromagnetic wave traveling through the space. Its
electric field is always orthogonal to the propagation direction, and it can be decomposed
in the perpendicular (Es) and parallel (Ep) components to the plan of incidence. If the
direction of the electric field is well defined, the light is called polarized. In ellipsometry,
the incident light is linear polarized, which means the electric field is confined to a single
plan along the direction of propagation. After reflection upon the surface, the light
become elliptical polarized, meaning the electric field describes an ellipse. The change
of the polarized state can be described by the ellipsometric parameters: the change in
the amplitude ratio due to reflection (ψ) and the phase difference (∆) of the parallel and
perpendicular components (Equation 4.2 and 4.3, respectively) [111]:
tanψ =
Eip/Eis
Erp/Ers
(4.2)
∆ = (δrp − δrs )− (δip − δis) (4.3)
These two angles are applied to evaluate the refractive index (n), the extinction co-
efficient (k) and the thickness of the film deposited onto the reflective substrate are ob-
tain [112].
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4.4 Optical contact angle (OCA)
Contact angle measurements are a non-destructive surface analysis which provide in-
formation about wettability of a surface. It also gives information about its free energy,
which is directly proportional to the tendency of water molecules to adsorb onto a mate-
rial surface. This technique is very useful to detect surface modifications, such as AMP
immobilization, and to predict future interactions with biological environments [63, 70,
73, 78].
The contact angle (θ) is the angle formed between the liquid and the material surface
(Figure 4.4). It results from the balance created between the attraction force of the liquid
molecules to each other (cohesive force) and the force of the liquid molecules interaction
with the solid surface (adhesive force). Hence, when a drop of liquid is placed on a
surface, it spreads to reach the equilibrium between cohesive and adhesive forces, with a
minimum energy state [113]. This is also valid when an air bubble is placed in a surface
immersed in a liquid.
Figure 4.4: Scheme of contact angle measurements: A) sessile drop technique and B)
captive bubble technique.
This equilibrium between forces can be described by different equations such as
Wenzel or Cassie equation, depending on the physical properties of the surface. However,
Young’s equation is ideal for smooth, rigid and homogeneous surfaces, being defined as:
cosθ =
γsv −γsl
γlv
(4.4)
where θ represents the contact angle, and γlv , γsv and γsl represent the interfacial
liquid-vapor, solid-vapor and solid-liquid tension, respectively [114].
If the contact angle is inferior to 90◦, i.e., γsv < γsl , the liquid is spreading over a
large area, demonstrating that wetting of the surface is favorable (hydrophilic). On the
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other hand, if the contact angle is greater than 90◦, i.e., γsv > γsl , the liquid minimizes
the contact with the surface and the surface is said to be non-wetting with the liquid
(hydrophobic) [115].
Among the various methods used for contact angle measurement, two of the most
common techniques are the static sessile drop and the captive bubble method. These
techniques are very sensitive since only the top nanometer of a surface influences wetta-
bility [116].
In the static sessile drop technique, a liquid droplet is released from a syringe and
deposited on the solid surface (Figure 4.4A). On the other hand, in the captive bubble
method, the solid sample is immersed in the testing liquid (e.g. water) and an air bubble
is injected underneath the sample through a J-shaped needle (Figure 4.4B). By applying
captive bubble method, we assure that the surface is in a saturated atmosphere, which
reduces contamination of surface and enables an equilibrium state with water phase
(surface energy unaltered) [116, 117]. The method is particularly suitable for solids with
high surface free energy on which liquids spread out. Hydrogels, such as soft contact
lenses for example, are likewise inaccessible for the standard arrangement; the captive
bubble method is also used in such cases [118].
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Materials and Methods
5.1 Dhvar5
The antimicrobial peptide Dhvar5 is a 14-amino sequence, LLLFLLKKRKKRKY (from
N to C: leucine-leucine-leucine-phenylalanine-leucine-leucine-lysine-lysine-arginine-
lysine-lysine-arginine-lysine-tyrosine) and was a kind gift from Professor Paula Gomes
group, from the Faculty of Science of University of Porto (FCUP). The peptide was syn-
thesized with an additional 6-aminohexanoic acid (Ahx) spacer and a Cysteine (Cys) at
N-terminal (hereafter designated Cys-Ahx-Dhvar5, MW = 2063.97 Da) or C-terminal
(hereafter designated Dhvar5-Ahx-Cys, MW = 2063.97 Da). Peptide purity degree was
determined by high performance liquid chromatography (HPLC), revealing a purity de-
gree above 93% for both peptides.
5.2 Chitosan purification
The reprecipitation method was used to purify high molecular weight chitosan (France-
Chitine), with a degree of deacetylation of 94% and MW > 500 kDa. Briefly, 1 g of
chitosan was firstly hydrated in 197.7 mL of distilled and deionized water (type II water),
for 24h at 4◦C under slow magnetic stirring. After that, 2.3 mL of glacial acetic acid (0.2
M) (Reag. Ph. Eur., for analysis, ACS, ISO) was added, under strong magnetic stirring,
and incubated at room temperature overnight. When solubilization was completed, the
resulting solution was filtered using a 20 µm pore size filter (Merck Millipore) and precip-
itated under stirring by dropwise addition of NaOH 1 M. To neutralize the pH, chitosan
was washed with type II water by multiples cycles of centrifugation until a pH of 7 was
reached. Finally, chitosan was freeze-dried and grounded in a laboratory mill (IKA mill)
to obtain the final powder. Purified chitosan powder was dried in a vacuum oven (Raypa)
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for 24h at 60◦C, before further use.
5.3 Dhvar5 thiol-ene “click” immobilization
5.3.1 Chitosan functionalization with norbornene
5.3.1.1 Solubilization of Chitosan in organic solvents
The norbornene-functionalized Chitosan (NorChit) was synthetized through the reaction
with carbic anhydride (CA, Acros Organics), as previously suggested by Pereira et al. [89].
Prior to synthesis, as CA is soluble only in organic or aqueous alkaline solvents, and chi-
tosan is soluble in aqueous acidic buffers, a co-solvent approach was pursued. Therefore,
a co-solvent with 40/60 (%v/%v) ratio of N,N-dimethylformamide (DMF, Merck)/acetic
acid 0.1 M ensured an homogenous and transparent chitosan solution with workable
viscosity. Firstly, 30 mg of chitosan were hydrated in 2955 µL of type I water for 8h,
followed by the addition of 18 µL of glacial acetic acid (Reag. Ph. Eur., for analysis, ACS,
ISO) and overnight incubation. In the next day, 27 µL of glacial acetic acid was added
and incubated for 10min. Finally, 4295 µL of DMF was dropwise added under strong
magnetic agitation, and solution was kept further under magnetic agitation for 30min, to
ensure solution homogeneity.
5.3.1.2 Carbic Anhydride (CA) reaction with chitosan
CA solution was freshly prepared in DMF (4.5 M), and 43 µL were added every half hour
(3 additions) to reach a concentration of 18 M, which corresponds to 1-fold molar excess
regarding hydroxyl and amine groups in the chitosan polymer backbone (Figure 5.1 a).
At each CA solution addition, 1000 µL acetic acid at 0.1 M was simultaneously added
to adjust chitosan viscosity (1:24 %v/%v of CA/acetic acid). After that, solution was
incubated at room temperature for 24h, under mild magnetic agitation and protected
from the light. The solution was transferred to dialysis (Thermo Scientific SnakeSkin
3.5 KDa MWCO Dialysis Tubing) with decreasing quantities of sodium chloride (NaCl)
(VWR chemicals) of 30 mg, 25 mg, 20 mg, 15 mg and 10 mg in 4 L of type II water.
Dialysis occurred for 2.5 days with NaCl, followed by a 1.5 day with type II water (dialysis
solution was changed twice a day). The final solution (NorChit) was subsequently frozen,
lyophilized (Labconco Freezone 2.5 Plus, Pmin = 0.008 mBar and Tmin = -80◦C) and
stored at a desiccator.
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Figure 5.1: Chitosan modification with a) Carbic Anhydride (CA) to form norbornene
groups; b) Dhvar5 immobilization by thiol-ene reaction.
5.3.2 Dhvar5 covalent immobilization
For thiol-ene linkage, 10 mg of NorChit were hydrated for 8h with 1985 µL of type I water
followed by the addition of 15 µL of glacial acetic acid and overnight incubation under
mild magnetic agitation. Then, 250 µL of either Dhvar5-Ahx-Cys or Cys-Ahx-Dhvar5 (6.5
mg) and 250 µL of 0.4% (m/V) VA-086 photoinitiator, all solubilized in acetic acid 0.1
M, was added to NorChit solution (Figure 5.1 b). Reaction occurred under UV light (365
nm, RoHS, Hamamatsu) at 10 mW/cm2 during 5min, under magnetic agitation. Then,
solutions were transferred to a dialysis membrane (10 kDA, Thermo Scientific) previously
hydrated in type II water for 30min. Dialysis was performed with decreasing quantities
of sodium chloride (NaCl) (VWR chemicals) (30 g, 20 g and 10 g NaCl) changed every
hour and, finally, type II water overnight. The solutions were frozen and lyophilized.
5.4 Chitosan-Dhvar5 powder characterization
Chitosan-modified powders NorChit, NorChit-Dhvar5 (Nt) and NorChit-Dhvar5 (Ct)
were characterized by Fourier-Transform Infrared spectroscopy (FTIR) and X-ray photo-
electron spectroscopy (XPS).
5.4.1 Fourier-Transform Infrared spectroscopy (FTIR)
FTIR spectra measurements were made using a Perkin-Elmer FTIR spectrophotometer
in transmission mode, using a deuterated triglycine sulfate detector (DTGS). All the
samples were pre-dried overnight in a vacuum oven (Raypa) at room temperature. Each 2
mg of the powder sample was blended with 200 mg of KBr, which was dried at 110◦C for
24h before usage. The KBr pellets were prepared in a uniaxial hydraulic press (Graseby
Specac) under 2min of vacuum followed by 30s at 8 T hydraulic pressure. For each
sample, 100 scans were collected with a 4 cm−1 resolution. Spectra were fitted using the
Spectrum GX FTIR (version 5.3) software.
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5.4.2 X-ray Photoelectron Spectroscopy (XPS)
For XPS analysis, samples were prepared by compressing the chitosan, NorChit and
NorChit-Dhvar5 (Nt) powders into thin pellets. Measurements were carried out on a
Kratos Axis Ultra HAS spectrometer (from CEMUP – Centro de Materiais da Universidade
do Porto) using aluminum (15 kV) as a radiation source. The analysis was made with
a take-off angle of 90◦ between the horizontal surface plane and the electron analyzer
optics. Survey spectra were collected over an energy range of 0-1350 eV with analyzer
pass energy of 80 eV. The high-resolution spectra of C1s was collected with analyzer pass
energy of 40 eV. The binding energy scales were referenced by setting the C1s binding
energy to 285.0 eV. The spectra fitting was done by using the CasaXPS (version 2.3.17PR
1.1) software.
5.5 Chitosan-Dhvar5 proteolytic stability assays
5.5.1 Competitive Kinetic test by using N-α-benzoylarginine ethylester
(BAEE) substrate
Evaluation of the enzymatic degradation of Dhvar5 by trypsin using N-α-Benzoyl-L-
arginine Ethyl Ester (BAEE) as substrate was adapted from [119]. Briefly, in the presence
of trypsin (from porcine pancreas, Sigma-Aldrich), BAEE substrate (Merck) hydrolyzes
to N-α-benzoylarginine (BA), increasing the absorbance (∆A253nm). The kinetic of this
hydrolyzation, and respective BA appearance, was compared in the presence and absence
of Dhvar5 in soluble form or immobilized onto chitosan. To optimize the assay protocol, a
Chitosan-Dhvar5 powder obtained by Copper (I)-catalyzed Azide-Alkyne Cycloaddition
was used, as an excess powder was available in the lab from previous works [69].
Firstly, a trypsin solution (13.83 µg/mL) in 50 mM TrisHCl at a pH = 7.1 or pH
= 8.5 (TrisHCl buffer) was prepared, depending on the final pH tested. Also, BAEE
(0.36 mg/mL) and Dhvar5 solutions (0.28 mg/mL) were prepared in TrisHCl buffer and
0.1 M acetic acid, respectively. Chitosan-Dhvar5 solution (3 mg/mL) was prepared by
pre-hydrating the powder with type II water during 8h, followed by glacial acetic acid
addition and overnight incubation (final concentration of 0.1 M). Thereafter, in a UV-
STAR microplate, 96-well (Greiner, 675801), mixture reaction were prepared by mixing
25.5 µL of trypsin, with 20 µL of BAEE solution and with (i) 10 µL of 0.1 M acetic acid
(positive control to the assay), (ii) 10 µL of Dhvar5 (negative control to the assay), or
(iii) 10 µL of Chitosan-Dhvar5 (TrisHCl was added until 100 µL in each well). BAEE
solution was used as blank to solution (i). To remove background noise in solutions (ii)
and (iii), wells were prepared as previously described but without the presence of trypsin.
The kinetic was assessed by measuring A253nm at room temperature, every minute, until
20min using a Biotek Plate Reader.
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5.6 Production of Chitosan-Dhvar5 coatings
5.6.1 Substrate preparation
Gold (Au) substrates (1 x 1 cm2) were used due to their higher suitability for surface
characterization techniques, such as ellipsometry and water contact angle. To remove
the photoresist layer from Au substrates, rinsing with acetone (99.5%, p.a, Merck) was
performed. Then, substrates were cleaned with “piranha” solution (7 parts of H2SO4 and
3 parts of 30% H2O2) for 5min, to remove organic contaminants from the surface. This
solution needs to be carefully managed due to its strong reactivity with many organic
solvents. Finally, substrates were washed successively with ethanol (99.9%, Merck), type
I water, ethanol (99.9%, Merck), and finally dried with a gentle steam of argon.
5.6.2 Preparation of Chitosan-Dhvar5 coatings
Chitosan and modified chitosan powders were dried in a vacuum-oven (Raypa) for 24h
at 60◦C or room temperature, respectively. Chitosan and modified chitosan solutions at
0.4% w/v concentration were obtained after hydration in type II water for 24h and sub-
sequent addition of acetic acid glacial (Reag. Ph. Eur., for analysis, ACS, ISO) overnight
(final acetic acid concentration of 0.1 M). Solutions were maintained at 4◦C until use
(within the same day). The chitosan-based coatings were produced on top of Au sub-
strates by spin-coating (Laurell Technologies Corporation (NorthWales, UK)). A 50 µL
drop of pre-filtered (MILLEX AA syringe filter unit, 0.8 µm, Merck) chitosan solution
was firstly deposited on the center of the Au substrates, and spun at 9000 rpm during
1min, followed by a second 50 µL drop of either chitosan (control samples) or modified-
chitosan solutions. Then, the coatings were neutralized twice with 0.1 M NaOH for 5min
and rinsed twice with type I water. Finally, each sample was dried with a gentle argon
stream and stored in plastic Petri dishes saturated with argon.
5.7 Surface characterization
5.7.1 Ellipsometry
Ellipsometry measurements were performed using an imaging ellipsometer, model
EP3, from Nanofilm Surface Analysis. This ellipsometer was operated in a polarizer-
compensator-sample-analyzer (PCSA) mode (null ellipsometry). The light source used
was a laser with a wavelength of 532 nm. The gold substrate refractive index (n = 0.670)
and extinction coefficient (k = 2.483) were determined by using a delta and psi spectrum
with a variation of angle between 61◦ and 71◦, and a Brewster angle of 68◦. The mea-
surements were performed in four zones to correct any instrument misalignment. The
35
CHAPTER 5. MATERIALS AND METHODS
thickness of the chitosan coating was determined using (n) chitosan = 1.54 and (k) chi-
tosan = 0 [120]. Results are presented as the average of two measurements on each of
three samples.
5.7.2 Water contact angle (WCA) measurements
Water contact angle measurements were performed in a goniometer model OCA 15,
equipped with a video CCD-camera and SCA 20 software (Data Physics), and by using
the captive bubble method. To pre-hydrate the samples, chitosan and modified-chitosan
samples were tape glued to a microscope slide and placed in a quartz chamber filled with
type II water for 10min, at room temperature. Subsequently, using a J-shaped syringe, 10
µL bubbles of room air, with a dose rate of 2.11 µL/s, were introduced to the immersed
surfaces. The bubble images were stored, and bubble profiles were fitted using ellipse
method, to calculate the contact angle. Results are the average of three measurements on
three independent samples.
5.8 Bacterial assays
5.8.1 Bacteria Strains and Growth Conditions
Staphylococcus epidermidis (ATCC 35984) and Staphylococcus aureus (ATCC 49230) were
obtained from the American Type Culture Collection. Bacteria were grown in Tryptic
Soy Agar (TSA, Merck) plates for 24h at 37◦C, to allow bacteria spreading, and after in
Tryptic Soy Broth (TSB, Merck) overnight at 37◦C and 150 rpm. Bacterial suspensions
were adjusted by measuring Optical Density (600 nm). Bacterial numbers were confirmed
by a retrospective viable count.
5.8.2 Determination of minimal inhibitory concentration (MIC) and
minimal bactericidal concentration (MBC) of Dhvar5 derivatives
Antimicrobial activity of Dhvar5, Dhvar5-Ahx-Cys and Cys-Ahx-Dhvar5 were firstly as-
sessed in solution, against S. epidermidis (ATCC 35984) and S. aureus (ATCC 49230),
by an adaptation of the microtiter broth dilution method proposed by Wiegand and
co-workers [121]. For this, peptide dilutions were prepared in acetic acid (0.01% v/v)
with bovine serum albumin (BSA) solution (0.2% w/v) in a range concentration from 0.5
µg/mL to 256 µg/mL. Bacteria inoculum (100 µL, 2x105 CFU/mL) in Mueller-Hinton
Broth (MHB) (Sigma-Aldrich) was added to a rounded-end shape microtiter 96-well plate
(Costar). This plate was chosen as it is made from polypropylene, which prevent binding
of the peptides to the walls of the wells and allow easy observation of bacteria pellet for-
mation. Dhvar5 and related-conjugates at each concentration were added (11 µL) to the
respective wells and incubated for 18-24h at 37◦C. Uninoculated MHB was added to the
last column as a control of sterilization. The MIC value was read, corresponding to the
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first well where visible bacteria growth was not observed. To determine the MBC values,
the content of the MIC and the following wells were successively diluted and plated in
TSA and incubated overnight. The MBC value corresponded to the concentration where
bacteria growth was not observed. The same assay was performed with peptides solutions
submitted to UV treatment, which is a requisite to perform the thiol-ene click immobi-
lization. Two replicates for each concentration were used. Two independent assays were
performed.
5.8.3 Surface bacterial adhesion and viability assay
The followed protocol was adopted from previous work [73]. Surfaces were disinfected
by incubating twice with ethanol 70% for 15min, rinsed twice with sterile type II water
for 15min, and then dried with argon in sterile environment. Au substrates, used as a
control, were cleaned prior to bacterial assays with “piranha” solution, as described in
section 5.6.1 and rinsed with ethanol and sterile type II water. A 5 µL drop of bacterial
solution (108 CFU/mL) in phosphate buffer saline (PBS) was deposited in the center
of each sample and a glass coverslip (Ø = 13 mm) was added to force contact between
bacteria and the surface. Surrounding wells were filled with sterilized type II water to
avoid medium evaporation, and samples were incubated at 37◦C for 5h. Sterile 0.9%
aqueous NaCl solution was added to each well, allowing the removal of the coverslip, and
rinsing with up and down. Substrates were further rinsed twice with NaCl solution and
then stained with 300 µL of a combination dye of the LIVE/DEAD Bacterial Viability Kit
(BaclightTM) for 15min, at room temperature and in the dark. Briefly, this kit contains
two fluorescent dyes, Syto9 which stains in green all the bacteria present, and propidium
iodide (PI) which only crosses the damage cells membranes staining in red those cells.
As PI suppresses the Syto9 fluorescent emission, it is workable to assume that green cells
represent live cells whereas red cells represent the dead ones. After incubation with the
LIVE/DEAD kit, samples were rinsed with 0.9% aqueous NaCl solution. Samples were
mounted in microscope slides using VECTASHIELD mounting media for microscopy
observation. Images were obtained with an inverted fluorescence microscope (Axiovert
200M, Zeiss, Germany) and acquiring ten fields on each sample with a 630x magnification
(using oil objective), corresponding to a net area of about 0.0381 mm2/sample. For each
sample three to six replicates were analyzed. In order to quantify the viability of the
adherent bacteria, a manual counting software included in ImageJ software was used.
5.9 Statistical analysis
Statistical analysis was performed using GraphPad Prism program, applying One-Way
ANOVA or Kruskal-Wallis with Dunn’s multiple comparison test. Data is expressed as
the mean ± standard deviation (SD) and p values < 0.05 were considered significant.
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Results and Discussion
6.1 Chitosan-Dhvar5 powder
6.1.1 Chemical characterization
Characterization of the unmodified and modified chitosan powders was performed
through Fourier-Transform Infrared spectroscopy (FTIR) and X-ray photoelectron spec-
troscopy (XPS). The chemical structures of chitosan, NorChit and NorChit-Dhvar5 are
represented in Figure 6.1.
Figure 6.1: Chemical structures of the chitosan, NorChit and NorChit-Dhvar5.
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6.1.1.1 FTIR
FTIR was performed to evaluate functionalization of chitosan with norbornene group
(NorChit) after reaction with carbic anhydride (CA) and Dhvar5 grafting (NorChit-
Dhvar5). The FTIR spectra obtained for chitosan, NorChit, NorChit-Dhvar5 (Nt) and
NorChit-Dhvar5 (Ct) powders are presented in Figure 6.2.
Figure 6.2: FTIR spectra of chitosan, NorChit, NorChit-Dhvar5 (Nt) and NorChit-Dhvar5
(Ct) powders.
Unmodified chitosan displayed characteristic peaks as reported before, including:
the broad and intense band at 3450-3200 cm−1 due to the overlapping contributions of
hydrogen-bonded X-H stretching vibrations [69]; the N-H bend at 1597 cm−1 [122]; the
peak at 1418 cm−1 assigned to O-H plane deformation (primary alcohol) [123]; the peak
at 1384 cm−1 which can be assigned to C-H vibrations in CH3 [124]; the peak at 1153
cm−1 assigned to the asymmetric C-O-C bridge [122]; and the intense peak at 1075 cm−1,
typical of C-O-C stretching in the glucopyranose ring [63].
The FTIR spectrum of NorChit presents four extra peaks (highlighted in dashed red
lines) when compared to chitosan: (i) at 2965 cm−1, which can be assigned to C=C bond
present in the norbornene group [125], (ii) at 1762 cm−1 related with C=O stretching
in ester groups [126, 127] (iii) at 1700 cm−1 assigned to C=O of the carboxylic acid
groups [128], and (iv) at 844 cm−1, as a signal of =C-H deformation vibrations for the C
double bond [129]. The shift of the chitosan peak at 1597 cm−1 (N-H bond in -NH2) to
1530 cm−1 (amide II) supports some of the chitosan’s amines reacted [130]. Furthermore,
the higher intensity of the amide I peak at 1640 cm−1 also supports partial consumption of
available amines upon reaction with norbornene [131]. The decrease of the peak intensity
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at 1418 cm−1 suggests the simultaneous use of the -OH groups in chitosan as binding
sites to norbornene [125].
The NorChit-Dhvar5 (Nt) and NorChit-Dhvar5 (Ct) spectra suggested that the desired
“click” reaction had occurred, as two significant changes could be notable when compar-
ing to NorChit: (i) strong intensification of the peak at 1640 cm−1 due to amide I and (ii)
intensification of the peak at 1530 cm−1 correspondent to the amide II (both present in
the peptide bonds) [69, 122, 132]. Moreover, the intensification of the peak at 1384 cm−1
(C-H vibrations in CH3) [124] suggests the success of the immobilization, which can be
justified by the abundance of this functional group in the peptide chain.
6.1.1.2 XPS
XPS analysis was performed to determine the atomic composition of the unmodified and
modified chitosan powders to evaluate the success of Dhvar5 grafting. XPS survey spectra
showed that no elements other than those expected were found, suggesting that no con-
tamination took place. The theoretical and experimental relative atomic percentages of
carbon (C), nitrogen (N), oxygen (O) and sulfur (S) of the different samples are described
in Table 6.1.
Table 6.1: Elemental analysis data (% C, N, O, S) determined by XPS analysis of chitosan,
NorChit and NorChit-Dhvar5(Nt) samples.
It is observable that the relative atomic percentages of carbon in all the samples was
slightly higher than the expected, which can be assigned to adventitious carbon from the
atmosphere that naturally deposits on the sample surfaces [133]. Consequently, when
comparing the relative percentages of the other components in the unmodified chitosan,
it is possible to observe that they were slightly lower than the expected. Nevertheless,
unmodified chitosan results are in accordance with previous reports [124].
Norbornene-functionalized chitosan sample (NorChit) presented an increased rela-
tive percentage of C, and a decrease in N and O content, which is in accordance with
theoretical composition reported in Table 6.1. Regarding the Dhvar5 immobilization,
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NorChit-Dhvar5 (Nt) sample was chosen as representative of this step. As shown is Ta-
ble 6.1 the success of thiol-ene “click” chemistry was firstly evidenced by the presence of
S2p due to the introduction of the thiol group. The N1s relative percentage augmented,
as expected, which can be assigned to the high N content that exist within peptide bonds,
and lateral chains. Also, the O content presented a decrease in the relative percentage,
which is in accordance with the tendency denoted in the theoretical composition. The ex-
tent/amplitude of these variations are not as expressive as in the theoretical composition,
which may be related to an immobilization yield lower than 100%.
High resolution XPS spectra of C1s was also analyzed. The C1s spectrum was resolved
into three peaks as previously described by Amaral et al. [124]. As shown in Table 6.2,
the peak at 285.0 eV was assigned to C-C and C-H bonds, the peak at 286.6 eV to C-NH2,
C-OH and C-O-C carbons, whereas the peak at 288.1 eV was assigned to O-C-O and
N-C=O carbon groups.
Table 6.2: C1s relative surface atomic composition of different chitosan samples.
The intensification of the peaks at 285.0 eV (carbon ring) and at 288.1 eV (amide bond)
in NorChit when compared to chitosan supports the introduction of the norbornene group
in chitosan.
Regarding NorChit-Dhvar5 (Nt), when comparing to NorChit, the presence of the
peptide is evidenced by the expressive increase at 285.0 eV peak (C-C and C-H assigned
to the peptide chain and to the spacer (Ahx)), adding to the increase at the 288.1 eV peak
(assigned to the amide from peptide bonds).
6.1.2 Competitive proteolytic assay with BAEE substrate to assess
Chitosan-Dhvar5 stability
One of the most challenging limitations concerning the clinical application of AMP is
related to its tendency to degrade in an enzymatic environment. In this sense, AMP immo-
bilization is expected to surpass this shortcoming. Hence, considering the future medical
application of the Chitosan-Dhvar5 coating in infected chronic wounds, the most rele-
vant enzymes to evaluate the immobilized peptide stability were matrix metallopeptidase
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9 (MMP9) or matrix metalloproteinase 2 (MMP2) [66], human neutrophil elastase [67,
134, 135] and Staphylococcus aureus V8 Protease [68, 85, 134]. However, considering the
results obtained after the application of an online simulation peptide cutter tool [136], it
was possible to verify that none of the relevant enzymes would degrade Dhvar5 sequence.
On the other hand, trypsin, a serine protease of 223 amino acid residues found in
the digestive system of many vertebrates, is usually used as an enzyme model for AMP
proteolytic studies [85, 119, 134, 135, 137, 138]. Trypsin reacts with peptide bonds be-
tween the C-terminal side of K and R amino acids and N-terminal of the adjacent residue
(Figure 6.3), being strongly active in a pH range between 7 and 9 [139, 140]. Hence,
trypsin was chosen to prove the proteolytic degradation resistance of the immobilized
AMP.
Figure 6.3: Dhvar5 possible cutting sites when incubated with trypsin.
A competitive assay in solution between Dhvar5 and N-α-benzoylarginine ethylester
(BAEE), a substrate for trypsin, was pursued, adapted from Marschutz et al. [119]. Trypsin
hydrolyzes BAEE to N-α-benzoylarginine (BA), which has a higher absorbance at A253nm.
By continuously measuring the absorbance, it would be expected to observe more degra-
dation of the BAEE when no other trypsin substrates are present in the mixture (Fig-
ure 6.4 a) (higher absorbance, positive control), minimum degradation when incubated
with free Dhvar5 and trypsin (lower absorbance, Figure 6.4 b) (negative control), and a
maximum-to-intermediate degradation when incubated with immobilized Dhvar5 and
trypsin (Figure 6.4 c).
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Figure 6.4: Schematic representation of competitive degradation assay in the presence of
a) trypsin and BAEE (maximum BA), b) free peptide, trypsin and BAEE (minimum BA)
and c) peptide immobilized onto chitosan, trypsin and BAEE.
Firstly, the degradation of free Dhvar5 (15 µM) was assessed. Results are presented
in Figure 6.5.
Figure 6.5: Hydrolysis of the BAEE substrate (20min at room temperature and pH = 7.1)
(BAEE) or BAEE substrate plus free Dhvar5 (15 µM) (Dhvar5) by trypsin (0.15 µM).
By analyzing the curves, it is possible to observe that a much lower degradation kinetic
of BAEE was obtained in the presence of free Dhvar5, suggesting that a competitive
degradation was occurring. The effect of the addition of chitosan (Chit), chitosan with
immobilized or free Dhvar5 (Chit-Dhvar5 and Chit + free Dhvar5, respectively) was then
assessed. Results are shown in Figure 6.6.
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Figure 6.6: Hydrolysis of BAEE substrate (20min at room temperature and pH = 7.1)
(BAEE), BAEE substrate plus free Dhvar5 (Dhvar5), BAEE substrate plus chitosan(Chit),
BAEE substrate plus Dhvar5 immobilized onto chitosan (Chit-Dhvar5), and BAEE sub-
strate plus chitosan and free Dhvar5 (Chit + free Dhvar5), by trypsin.
Both BAEE and Dhvar5 curves presented similar degradation speed as before.
The degradation of BAEE was hindered in the presence of Chit-Dhvar5, revealing a
much slower degradation kinetic when compared with BAEE kinetic. The decrease in the
BA absorbance can have different origins. It does not seem to be related to a competitive
degradation of the immobilized Dhvar5, as the absorbance of the mixture BAEE and free
Dhvar5 (Dhvar5) presented degradation, with correspondent BA absorbance augmenta-
tion. Instead, it can be hypothesized that this absorbance decrease may be related to (i)
possible “entrapment” of trypsin within chitosan polymer chains, as chitosan solutions
have high viscosity [73] and/or (ii) trypsin inactivation due to a more acidic pH in the re-
action mixture that include chitosan solvents. Chitosan is only soluble in acidic solutions
with pH below to 6.5 [141]. Therefore, to ensure the correct solubilization of the polymer,
chitosan was firstly dissolved in acetic acid 0.1 M, and then diluted in TrisHCl buffer pH
7.1. Hence, the final pH of the solutions with chitosan is more acidic when compared
with the others, which have a pH of 7.1. Since trypsin activity is pH sensitive [140], BAEE
degradation can be affected by the different pH values.
To assess the extent of detrimental effect of more acidic pH in the enzymatic activity,
trypsin was tested in different pH’s between 4 and 8.5, as displayed in Figure 6.7.
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Figure 6.7: Hydrolysis of BAEE substrate by trypsin at different pH’s (room temperature).
The results confirmed the dependence between trypsin activity and pH. At a pH =
4, trypsin did not degrade BAEE. On the other hand, trypsin was clearly active at a pH
of 8.5. In a pH of 6.5 although there was a decrease in the BAEE degradation rate when
compared to 8.5, trypsin activity was also expressed. Mao et al. had already reported the
pH dependence of this enzyme, showing the highest trypsin activity at pH 7.8-8.1 and,
moreover, enzyme remained 80% at pH 7.2 [140]. Nevertheless, there are also reports
describing the stability of this enzyme at lower pHs [142].
In this sense, a pH of 6.1 was followed to ensure chitosan solubility without completely
inactivate trypsin. To assure all the solutions had the same pH, acetic acid was added in
BAEE and Dhvar5 solutions in the same proportion than in chitosan’s solutions. Figure 6.8
depicts the results obtained at pH = 6.1.
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Figure 6.8: Hydrolysis of BAEE substrate (20min at room temperature and pH = 6.1)
(BAEE), BAEE substrate plus free Dhvar5 (Dhvar5) and BAEE substrate plus immobilized
Dhvar5 onto chitosan (Chit-Dhvar5), by trypsin.
No significant differences were observed between kinetics. This may be suggestive that
trypsin activity is attenuated at pH = 6.1, which consequently hamper the observation of
the differences in BAEE degradation.
Hence, the competitive proteolytic assay using BAEE substrate is inconclusive since
the pH cannot be increased due to the pH threshold for chitosan solubilization.
The competitive proteolytic assay measures the AMP degradation by an indirect
method, which implies the need of other characterization techniques to obtain a more
complete overview of the Chit-Dhvar5 stability. Two direct methodologies will be ad-
dressed in the future: high performance liquid chromatography (HPLC) and amino acid
analysis (AAA). HPLC allows to identify and quantify the amount of degraded Dhvar5
released to the supernatants of the degradation reaction mixture. AAA will quantify the
amount of Dhvar5 immobilized onto chitosan before and after degradation assay.
6.2 Chitosan-Dhvar5 coatings
6.2.1 Surface characterization
The successful development of the modified chitosan coatings was assessed by ellipsom-
etry and water contact angle (WCA) measurements. Unmodified chitosan coatings were
used as a control.
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6.2.1.1 Ellipsometry
Ellipsometry was used to explore possible differences in the thickness of the coatings.
The thickness of chitosan, NorChit and NorChit-Dhvar5 coatings are represented in Fig-
ure 6.9.
Figure 6.9: Surface thickness of chitosan and modified chitosan samples measured by
ellipsometry (n=3). Statistical analysis was performed by non-parametric Kruskal-Wallis
analysis and statistical differences are indicated with ** (p < 0.01) and **** (p < 0.0001).
The spin-coating process was chosen as it produces uniform, ultrathin and easily
reproducible films [143]. This technique allowed the creation of chitosan coatings with
31.1 ± 1.6 nm thickness, NorChit coatings with 17.6 ± 0.8 nm, and NorChit-Dhvar5 (Nt)
and NorChit-Dhvar5 (Ct) coatings with 16.1 ± 0.4 nm and 13.6 ± 1.0 nm, respectively.
Results show a significant decrease in thickness in NorChit coatings when compared
to control chitosan. This could be explained by the observable differences in viscosity be-
tween the chitosan and NorChit or NorChit-Dhvar5 solutions. It is known that solutions
with lower viscosities give rise to thinner films [144]. The introduction of the norbornene
group into the chitosan backbone, improved chitosan solubilization, which explains its
lower viscosity. Indeed, in Barbosa et al. work [73], where chitosan was functionalized
with azide moieties at its free amines, also a lower viscosity than the initial chitosan was
reported.
Regarding NorChit-Dhvar5 coatings, no significant thickness difference was observed
between samples with Dhvar5 immobilized and norbornene-functionalized chitosan (Nor-
Chit), neither between both NorChit-Dhvar5 (Nt and Ct).
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6.2.1.2 WCA measurements
Contact angle measurements were made using captive bubble method as depicted in
Figure 6.10.
Figure 6.10: WCA measurements of chitosan, NorChit, NorChit-Dhvar5 (Nt) and NorChit-
Dhvar5 (Ct): A) Schematic view of captive bubble method (θ: contact angle) of the dif-
ferent samples; B) Graphical representation of WCA results. Statistical analysis was
performed by One-Way ANOVA analysis and statistical differences are indicated with *
(p< 0.05).
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The values observed in the control chitosan are according to the reported by Barbosa
et al. [73].
The introduction of the norbornene moiety onto chitosan resulted on a decreased
water contact angle from 36.8 ± 6.8◦ in chitosan coatings to 30.3 ± 1.7◦ in NorChit
coatings. This can be explained by the chemical structure of norbornene, namely the
-COOH functional groups (Figure 6.1), which may allow further hydrogen bonds with
the water. Regarding the coatings with the peptide, no significant wettability difference
was observed between both samples (34 ± 4.6◦ for NorChit-Dhvar5 (Nt) and 36.7 ± 3.9◦
for NorChit-Dhvar5 (Ct)). As Dhvar5 have a head-to-tail amphipathic character, it was
expected to observe a wettability difference between both samples [63, 73]. However, as
the peptide was immobilized previously to the coatings production, is possible that its
conformation within the polymer hinder the observation of a wettability shift. Moreover,
as at this point the quantification of the peptide at the surface was not performed yet, it
is also possible that the lack of wettability difference, is actually the result of different
peptides density at the samples.
6.3 Bacterial Assays
Before assessing the antimicrobial activity of NorChit-Dhvar5 samples, Dhvar5 peptide
and its derivatives were firstly evaluated in solution.
6.3.1 Dhvar5 and derivatives minimal inhibitory concentration (MIC) and
minimal bactericidal concentration (MBC)
To assess the influence of the addition of the spacer (Ahx) and cysteine (Cys) residue
in the antimicrobial activity of the peptide, Dhvar5 and Dhvar5-based conjugates were
tested against S. epidermidis and S. aureus. In addition, the effect of UV light exposure
on Dhvar5 bactericidal capacity, as well as for one of its derivatives (Cys-Ahx-Dhvar5),
was also tested against S. epidermidis. The results (MIC and MBC values) are given in
Table 6.3.
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Table 6.3: Minimal inhibitory concentration (MIC) and minimal bactericidal concentra-
tion (MBC) values of Dhvar5, Dhvar5-Ahx-Cys and Cys-Ahx-Dhvar5 against S. epider-
midis and S. aureus before and after exposure to UV light.
Dhvar5 displayed antimicrobial activity against S. epidermidis at a concentration of 0.5
µg/mL, which was the value obtained both in MIC and MBC analysis. This is lower than
the reported previously by Barbosa et al. (MIC = 2 µg/mL and MBC = 16 µg/mL) [73].
Regarding S. aureus, a MIC value of 8-16 µg/mL was obtained, which is higher than the
reported by Barbosa et al. (4 µg/mL) [73] and Costa et al. (0.5 µg/mL) [63]. Nevertheless,
its MBC value (32 µg/mL) is in accordance with the reported one [73]. The differences
observed in the obtained MIC and MBC regarding previous reports may be related to
the different methods used to quantify peptides. Depending on the chosen method, the
quantification of the peptides can diverge [145], which consequently will alter the initial
and subsequent concentrations of the dilutions in MIC assay.
The introduction of the spacer (Ahx) and cysteine (Cys) to Dhvar5, promoted an
increase of MIC values. Nevertheless, the activity observed is still at a low and promising
concentration. In general, the MBC values were the same range or 2-fold higher than MIC,
indicating bactericidal effect of the peptide. The introduction of an extra Cys residue to
the parent sequence of an AMP have resulted differently in the past. Chen et al. found that
the Cys addition to an AMP did not affect MIC values [146]. On the other hand, Cleophas
et al. reported a slight decrease in AMP activity by elongating the peptide sequence with
a Cys residue [87].
Moreover, no significant differences observed between the peptide derivates (Cys-Ahx-
Dhvar5 and Dhvar5-Ahx-Cys), which suggests that antimicrobial activity of the peptide
in solution is independent of the terminal used for the addition of the spacer and thiol
group. Both MIC and MBC values were higher for S. aureus than for S. epidermidis,
demonstrating that S. epidermidis is more susceptible to Dhvar5 than S. aureus strains,
which is in accordance to previous works [73].
Importantly, no difference in the antimicrobial activity of Dhvar5 derivatives after
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UV light exposure, which guarantee its stability in the following immobilization steps
through photoinitiated thiol-ene reaction.
6.3.2 Surface bacterial adhesion and viability
To assess the antimicrobial activity of the coatings developed with the NorChit-Dhvar5
powder, an adhesion and viability assay was performed against S. epidermidis. Repre-
sentative images and correspondent number of live and dead bacteria adhered to the
different coatings are demonstrated in Figure 6.11 and 6.12, respectively.
Figure 6.11: Representative images of the adhered bacteria in unmodified and modified
chitosan samples by using LIVE/DEAD Bacterial Viability Kit (BacklightTM) staining.
Dead bacteria are represented in red while live bacteria are represented in green. An
inverted fluorescence microscope was used with a magnification of 630x.
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Figure 6.12: Viability of adhered S. epidermidis after 5h incubation in 37◦C. Statistical
analysis was performed by using non-parametric Kurskal-Wallis analysis and statisti-
cal differences are represented with *, ∆ and • for DEAD, LIVE and TOTAL bacteria,
respectively (• for p < 0.05; ** for p < 0.01; ****, ∆∆∆∆ and • • •• for p < 0.0001).
Chitosan films presented bactericidal effect, as it was possible to observe 47% of ad-
hered dead bacteria in the surface. This was an expected result, as the antimicrobial
effect of chitosan thin films have already been reported in the past [63, 73]. The func-
tionalization of chitosan with a norbornene moiety resulted in ∼20% decrease of the total
number of adhered bacteria, but also ∼50% decrease in dead adhered bacteria. It is well
accepted that chitosan protonated amines are involved in chitosan’s antimicrobial activity,
due to its electrostatic interaction with the negatively charged bacterial membranes [147].
Hence, it is possible that the decrease of available amine groups with the introduction of
norbornene moieties, promote loss of antimicrobial activity in NorChit samples.
On the other hand, both peptide coatings (NorChit-Dhvar5 (Nt) and NorChit-Dhvar5
(Ct)) presented a ∼75% decrease in live adhered bacteria comparing with chitosan and
NorChit films. Slightly different profiles were observed according to the Dhvar5 terminal
exposed. When compared to chitosan, NorChit-Dhvar5 (Ct) with N-terminal exposure
caused a higher augment in dead bacteria (∼65%), while in NorChit-Dhvar5 (Nt), expos-
ing the C-terminal, no significant difference was observed. Regarding the total number
of adhered bacteria, it is observable that NorChit-Dhvar5 (Nt) had much lower number of
bacteria adhered (less 35% and 18% than Chit and NorChit, respectively), while NorChit-
Dhvar5 (Ct) presented a much smoother effect with a 12% or no reduction in comparison
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to chitosan and NorChit, respectively. Others have reported upon the impact of the AMP
terminal used on immobilization, on the final antimicrobial profile of the surface. In
Hilpert et al. [148] and Barbosa et al. [73] work, higher bactericidal activity was found
when the hydrophobic terminal of the AMP is exposed. On the other hand, Costa et
al. [63] and Chen et al. [146] reported that the exposure of the cationic terminal of the
AMP seems to be the key in reducing the total number of adhered bacteria. In the work
herein reported, it was found greater bactericidal effect when the hydrophobic domain
is exposed (NorChit-Dhvar5 (Ct)), but lower number of total adhered bacteria when the
cationic domain is exposed (NorChit-Dhvar5 (Nt)). Importantly, the total adhered bacte-
ria decrease is also accompanied by a significant decrease in viable bacteria, prompting
its further development towards and efficient antimicrobial coating. These are promising
results which demonstrate the potential of improving chitosan antimicrobial activity by
AMP functionalization.
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Conclusions
The current work aimed at developing a new antibiotic-free dressing to be used for pre-
vention or mitigation of chronic wounds (CW) infections. For this, an antimicrobial
peptide (AMP) was immobilized onto chitosan through photoinitiated thiol-ene “click”
chemistry, and the obtained biopolymer was applied onto coatings production.
Firstly, chitosan was successfully functionalized with norbornene to be covalently
linked to Dhvar5. Cysteine-modified Dhvar5 was grafted by either terminal (N- or C-
terminal). The success of the immobilization was revealed by the peptide characteristic
amide peaks in the FTIR spectra and the appearance of sulfur and increase in nitrogen
content in XPS analysis, in NorChit-Dhvar5 powder. To evaluate NorChit-Dhvar5 stabil-
ity regarding proteolytic degradation, a competitive kinetic assay was performed with
trypsin in the presence of the trypsin substrate N-α-benzoylarginine ethylester (BAEE).
However, the results were inconclusive due to a pH mismatch between pH threshold for
chitosan solubilization and the optimum pH range for trypsin activity.
The NorChit-Dhvar5 coating was successfully deposited on gold plates by spin-
coating, presenting a low thickness (∼16nm) and with similar wettability to chitosan.
Bacterial assays demonstrated that the NorChit-Dhvar5 coatings improved antimicro-
bial activity when compared to chitosan, both with much lower live adhered bacteria
(∼75%). Furthermore, the antimicrobial properties depended on the exposed domain of
the peptide. Although both coatings presented similar number of live bacteria, NorChit-
Dhvar5(Nt) also reduced the total number of adhered bacteria in ∼35%.
Altogether, the work herein reported supports the use of photoinitiated thiol-ene
“click” chemistry as an efficient and highly selective method for AMP immobilization onto
chitosan. Moreover, the promising results obtained prompts the further development of
this biomaterial for antimicrobial wound dressing applications.
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Future perspectives
Regarding future work and in order to continue the development of the chitosan-based
dressing, it would be necessary to perform some complementary experiments. Firstly,
an alternative assay to evaluate the immobilization impact on AMP proteolytic stabil-
ity should be pursued. Regarding antimicrobial assays, other relevant bacterial strains
present in infected-CW, such as Staphylococcus aureus and Pseudomonas aeruginosa, should
be tested, and biofilm-prevention assays should be performed. Envisaging the future
biomedical application, additional studies such as evaluation of cytocompatibility (cell
interaction and adhesion) and in vivo studies may also be performed. Finally, to achieve
the highest rates of cost-effectiveness on Chitosan-AMP coating production, other types
of coating deposition procedures more adjusted for an industrial application should be
tested.
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